Resources

Type of publications
Regions
Diseases

5192 results found

2022 ∙ Cascini, Fidelia Pantovic, Ana Al-Ajlouni, Yazan A. Failla, Giovanna Puleo, Valeria Melnyk, Andriy Lontano, Alberto Ricciardi, Walter

Social media and attitudes towards a COVID-19 vaccination: A systematic review of the literature

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Alhumaid, S. Rabaan, A. A. Dhama, K. Yong, S. J. Nainu, F. Hajissa, K. Dossary, N. A. Alajmi, K. K. Saggar, A. E. A. AlHarbi, F. A. Aswany, M. B. Alshayee, A. A. Alrabiah, S. A. Saleh, A. M. Alqarni, M. A. Gharib, F. M. A. Qattan, S. N. Almusabeh, H. M. AlGhatm, H. Y. Almoraihel, S. A. Alzuwaid, A. S. Albaqshi, M. A. Khalaf, M. A. A. Albaqshi, Y. A. Brahim, A. H. A. Al Mutared, M. M. Al-Helal, H. Alghazal, H. A. Al Mutair, A.

Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Aaby, P. Nielsen, S. Fisker, A. B. Pedersen, L. M. Welaga, P. Hanifi, S. M. A. Martins, C. L. Rodrigues, A. Chumakov, K. Benn, C. S.

Stopping Oral Polio Vaccine (OPV) After Defeating Poliomyelitis in Low- and Middle-Income Countries: Harmful Unintended Consequences? Review of the Nonspecific Effects of OPV

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Poliomyelitis
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ McCosker, Laura K. El-Heneidy, Asmaa Seale, Holly Ware, Robert S. Downes, Martin J.

Strategies to improve vaccination rates in people who are homeless: A systematic review

  • All age groups
  • Hepatitis A
  • Hepatitis B
  • Influenza
  • Acceptance
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Singh, P. Dhalaria, P. Kashyap, S. Soni, G. K. Nandi, P. Ghosh, S. Mohapatra, M. K. Rastogi, A. Prakash, D.

Strategies to overcome vaccine hesitancy: a systematic review

  • All age groups
  • Parents/caregivers
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Ismail, S. A. Lam, S. T. Bell, S. Fouad, F. M. Blanchet, K. Borghi, J.

Strengthening vaccination delivery system resilience in the context of protracted humanitarian crisis: a realist-informed systematic review

  • All age groups
  • Logistics
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Sabbar, H. Mahraoui, C. Bastìas Garcià, M. Jroundi, I.

Streptococcus pneumoniae vaccination strategies and its expected impact on penicillin non-susceptibility in children under the age of five: Let's recap!

  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chiapponi, C. Faust, M. Schmidt, M. Thomas, M. Schultheis, A. M. Akgul, B. Alakus, H.

Subacute thyroiditis after SARS-Cov2 vaccination: A review of the cases being described and personal experience

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Rayatdoost, E. Rahmanian, M. Sanie, M. S. Rahmanian, J. Matin, S. Kalani, N. Kenarkoohi, A. Falahi, S. Abdoli, A.

Sufficient Sleep, Time of Vaccination, and Vaccine Efficacy: A Systematic Review of the Current Evidence and a Proposal for COVID-19 Vaccination

  • Adults
  • Healthcare workers
  • COVID-19
  • Influenza
  • Hepatitis A
  • Hepatitis B
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Tantawichien, T. Hsu, L. Y. Zaidi, O. Bernauer, M. Du, F. Yamada, E. Kim, J. O. Sukarom, I.

Systematic literature review of the disease burden and vaccination of pneumococcal disease among adults in select Asia-Pacific areas

  • South-East Asia
  • Western Pacific
  • Adults
  • Older adults
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...